Clinical Trial Update: Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous stem cell transplantation for chronic myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: WITHDRAWN